首页> 外文期刊>International Scholarly Research Notices >Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity againstCandida albicans
【24h】

Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity againstCandida albicans

机译:伊曲康唑脂质体给药系统及其对白色念珠菌的抗霉菌活性

获取原文
获取外文期刊封面目录资料

摘要

Niosomes have potential applications in topical drug delivery system. The objective of the study was to formulate and evaluate the niosome of Itraconazole. Surfactant : cholesterol ratio and quantity of ethanol used were studied by applying factorial design. Formulated niosomes were evaluated for vesicle size, entrapment efficiency, drug release, skin permeation, and antimycotic activity. Vesicle size, entrapment efficiency, and drug release were markedly dependent on surfactant : cholesterol ratio and quantity of ethanol used. Permeation of the drug through the skin was affected by cholesterol content in formulation. Itraconazole niosome were having larger zone of inhibition than marketed formulation when activity was checked againstC. albicans. Niosomes may be a promising carrier for topical delivery of Itraconazole especially due to their simple production.
机译:脂质体在局部药物递送系统中具有潜在的应用。该研究的目的是配制和评估伊曲康唑的脂质体。应用析因设计方法研究了表面活性剂:胆固醇的比例和乙醇的使用量。评价配制的脂质体的囊泡大小,包封率,药物释放,皮肤渗透和抗真菌活性。囊泡的大小,包封效率和药物释放明显取决于表面活性剂:胆固醇的比例和所用乙醇的量。药物通过皮肤的渗透受制剂中胆固醇含量的影响。当检查抗C活性时,伊曲康唑脂质体比市售制剂具有更大的抑制区。白色的。脂质体可能是伊曲康唑局部递送的有希望的载体,特别是由于它们的简单生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号